Navigation Links
Gentiva(R) Health Services Signs Agreement to Acquire Home Health Agency with Offices in Mississippi and Alabama
Date:7/23/2009

ATLANTA, July 23 /PRNewswire-FirstCall/ -- Gentiva Health Services, Inc. (Nasdaq: GTIV), a leading provider of comprehensive home health services, announced today that it has signed a definitive agreement to purchase Magna Home Health, a part of the Rush Health System, located in central Mississippi and west central Alabama. Both states require a certificate of need (CON) by county to participate in the home health program.

With the addition of Magna's locations in Meridian, Mississippi, and Gilbertown, Alabama, Gentiva will expand its coverage with seven new CON counties. Gentiva already has a significant presence in these states under the Gilbert's brand in Mississippi and the Mid South brand in Alabama.

"This acquisition will solidify Gentiva's role as the pre-eminent home health provider in those two states," said Gentiva CEO and President Tony Strange. "We look forward to welcoming Magna's employees to the Gentiva family, as we have with our two other recent acquisitions. Not only do these mergers allow our company to provide a high standard of compassionate care to a larger patient population, but they demonstrate our appetite and ability to be competitive in a consolidation environment spurred by healthcare reform."

The purchase is expected to close in third quarter of this year and will be funded from Gentiva's existing cash reserves. The acquisition is not expected to have a material impact on Gentiva's financial position or results of operations in 2009.

About Gentiva Health Services, Inc.

Gentiva Health Services, Inc. is a leading provider of comprehensive home health services, delivering innovative, high quality care to patients across the United States. Gentiva is a single source for skilled nursing; physical, occupational, speech and
'/>"/>

SOURCE Gentiva Health Services, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Gentiva(R) Health Services Schedules Second Quarter Earnings Call and Web Cast for Thursday, July 30, 2009
2. Gentiva(R) Health Services Acquisition Extends Certificate-of-Need Coverage in West Virginia
3. Gentiva(R) Health Services Acquires Louisiana Home Health Agency
4. Gentiva(R) Health Services to Present at Jefferies 3rd Annual Healthcare Conference
5. Gentiva(R) Health Services Receives Nasdaq Notification Regarding Independent Director Requirement
6. Gentiva(R) Health Services to Present at Deutsche Bank 34th Annual Health Care Conference
7. Gentiva(R) Health Services Schedules First Quarter Earnings Call and Web Cast for Thursday, April 30, 2009
8. Gentiva(R) Health Services to Present at Upcoming Investor Conferences
9. Gentiva(R) Health Services Sells Selected Pediatric Home Health Care Branches
10. Gentiva(R) Health Services Schedules Fourth Quarter and Fiscal 2008 Earnings Call and Web Cast for Wednesday, February 18, 2009
11. Gentiva(R) Health Services to Present January 13 at J.P. Morgan Healthcare Conference in San Francisco

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... Evaluation and Treatment Clinic...stock (Vocus) December 3, 2009 -- Centegra Health ...and H1N1 vaccine shots at four Centegra Primary Ca...ent of vaccine has arrived. The clinics are at CPC...enry and will be open as follows: ,   F...
(Date:12/3/2009)... new findings, doubts linger about whether they ca...(HealthDay News) -- Whether cell phones cause brai... a new study confirms previous evidence suggesting...e incidents of brain tumors in Scandinavia found n... phone use became widespread, according to the rep...
(Date:12/3/2009)... , LONDON, Dec. 3 Chiltern I... research organization (CRO) providing clinical de...ricas and Asia, today announces the appointment of...lobal Quality & Medical Affairs. Dr. Moore is .... ,, Dr. Moore is a physician with 15 years of ...
(Date:12/3/2009)..., PHOENIX, Dec. 3 The day has co...he nation,s most prominent direct-care RN organiza...r the founding convention of the new 150,000-membe... professional association in U.S. history. ,, A...note address to the convention which will chart a ...
(Date:12/3/2009)... , Recent CBO analysis understates key fact...ec. 3 A new actuarial a...nnual medical claims in the new individual market ... years after implementation of healthcare reform u...t (PPACA), excluding the impact of medical inflati...
Breaking Medicine News(10 mins):Health News:Centegra H1N1 Vaccination Clinics Continue 2Health News:Centegra H1N1 Vaccination Clinics Continue 3Health News:Centegra H1N1 Vaccination Clinics Continue 4Health News:No Increase in Brain Tumors Seen From Cell Phones 2Health News:No Increase in Brain Tumors Seen From Cell Phones 3Health News:Chiltern Names Dr. Sharon Moore as Executive VP, Global Quality & Medical Affairs 2Health News:RN SuperUnion Founding Convention Opens Monday 2Health News:New Actuarial Analysis Shows Senate Bill Would Significantly Raise Premiums 2Health News:New Actuarial Analysis Shows Senate Bill Would Significantly Raise Premiums 3Health News:New Actuarial Analysis Shows Senate Bill Would Significantly Raise Premiums 4
...healthcare advisory services firm, announced today...s Karpook and Gregory Maddrey to the position of,P...ng healthcare,organizations in advancing their str...and Pam are senior advisors with vast industry,exp...
...ol Shootings, LOS ANGELES, March 5 On February 1...th shooter in the past,decade under the influence ...rug regulatory agencies to cause suicide, mania, p...ling 54,dead and 105 wounded, the mental health wa...
...at 8:00 am, the Bowen Foundation for Autism will h...s to raise money to fight autism. For a,registrati...tiful 5K,waterfront course complete with activitie...e awareness and resources for,the prevention, trea...
...in Your Teeth, VOORHEES, N.J., March 5 Federal t...imilar for 2007. Together with the,government,s ec...,200 or,more back in the pockets of most taxpayers...investment with that money. According to Dr. Jack ...
...duced at all NHS Hospital Trusts a study by resear...at smoking is still prevalent, even by staff in un...ealth Sciences conclude that effective enforcement...moking on site. , The study was carried out to d...
...ime reasons why, study finds , , WEDNESDAY...gers in automobiles that crash are more likely to ...ecially if the car is being driven by a young, ine...ers in this age group died in car crashes. , "We w...
Other Medicine News:Health News:The Chartis Group Elects New Partners: Four Healthcare Industry Experts Promoted to Principal 2Health News:The Chartis Group Elects New Partners: Four Healthcare Industry Experts Promoted to Principal 3Health News:New Mini-Documentary Exposes Psychiatric Drugs Turning Kids into Killers 2Health News:New Mini-Documentary Exposes Psychiatric Drugs Turning Kids into Killers 3Health News:Inaugural Bowen Foundation Run/Walk to Fight Autism in Maryland Set for Saturday, March 29 2Health News:Smile When You Get that Refund 2Health News:Hospitals still not smoke-free 2Health News:Teen Passengers at Higher Death Risk in Car Crashes 2Health News:Teen Passengers at Higher Death Risk in Car Crashes 3
(Date:12/3/2009)... HOERSHOLM, Denmark and SAN DIEGO, California, Dec...ssfully Inhibits miR-122, a microRNA Important for...tly Reducing Hepatitis C,Virus in the Bloodstream ...itis C Virus , - SPC3649 Demonstrates Eff...Serious Adverse Events in the Treated Animals - Si...
(Date:12/3/2009)... Dec. 3 Cardium Therapeu...holly-owned subsidiary, Tissue Repair Company, sub... the U.S. Food and Drug Administration (FDA) seeki...duct candidate based on positive data from the Com... study. Today,s submission with the FDA covers Ex...
(Date:12/3/2009)...alif., Dec. 3 Jazz Pharm...that Kathryn E. Falberg has been appointed Senior ...alberg brings to Jazz Pharmaceuticals more than 20...e. As Jazz Pharmaceutical,s CFO, Ms. Falberg will...orate finance, financial planning, investor relati...
Breaking Medicine Technology:New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 2Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 3Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 4Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 5Weight Watchers 28R 29 Launches New Community on WeightWatchers com 55510 1Weight Watchers 28R 29 Launches New Community on WeightWatchers com 55510 2Weight Watchers 28R 29 Launches New Community on WeightWatchers com 55510 3Get Ready for Gruesome Cigarette Warnings 55508 1Get Ready for Gruesome Cigarette Warnings 55508 2Get Ready for Gruesome Cigarette Warnings 55508 3Mindray Medical to Participate in the SIG Third Annual Beijing Management Summit 55505 1Mindray Medical to Participate in the SIG Third Annual Beijing Management Summit 55505 2
...Form Medical,Inc. (Nasdaq: BFRM ) today announced...nded comparative study of nasolabial fold treatmen...Radiesse(R) dermal filler,than reported after trea...results of this study were published in the Decemb...c Surgery, a peer-reviewed publication of the,Amer...
...ent in Motor Function at 24 Months, SAN DIEGO, De...llow-up data from a Phase 1 clinical trial of CERE...ase. CERE-120 uses gene therapy to,deliver the neu...eurodegeneration that occurs in the brains of Park...ssments at 18 and 24 months post,treatment, sugges...
Other Medicine Technology:Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 2Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 3Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 4Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 5Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 6Ceregene Presents Long-term Follow-up From Phase 1 Trial of CERE-120 in Parkinson's Disease 2Ceregene Presents Long-term Follow-up From Phase 1 Trial of CERE-120 in Parkinson's Disease 3Ceregene Presents Long-term Follow-up From Phase 1 Trial of CERE-120 in Parkinson's Disease 4
Streck-Kleen Enzymatic Cleanser
Streck-Diluent III Plus Balanced Electrolyte Solution
Streck-CN free Lyse CD Lytic Reagent
...ted red blood cell (nRBC) control for evaluating t... 755 hematology analyzer in its enumeration of the...r LH 750/LH 755. nRBC-Chex for LH is a two-level c...nRBC-Chex for LH has a 75-day closed-vial stabilit...
Medicine Products: